10 mM solution of cyclic nucleotides dissolved in 250 µl water in 1.4 ml polypropylene vials in 96 (8 x 12) well polypropylene racks. Purity of compounds: typically > 98% HPLC. Supporting datasheet and electronic datafiles (ISIS™/BASE and MSExcel) on CD.
Current contents:Parent Structure: cAMP (
A 001)
1-modified cAMP Analogues: 1,N
6-ε-cAMP (
E 001); 1,N
6-ε-2-aza-cAMP (
A 015); 1-NO-cAMP (
A 023); Sp-5,6-DCl-cBIMPS (
D 014); 5,6-DM-cBIMP (
D 001)
2-modified cAMP Analogues: 2-AHA-cAMP (
A 053); 2-Cl-8-MA-cAMP (
C 080); 2-Cl-cAMP (
C 020); Rp-2-Cl-cAMPS (
C 073); Sp-2-Cl-cAMPS (
C 074); Rp-5,6-DCl-cBIMPS (
D 013); Sp-5,6-DCl-cBIMPS (
D 014); 5,6-DM-cBIMP (
D 001); 2-NH2-cPuMP (
A 027)
6-modified cAMP Analogues: 6-Bn-cAMP (
B 008); 6-Bnz-cAMP (
B 009); Sp-6-Bnz-cAMPS (
B 040); 6-Cl-cPuMP (
C 002); Sp-6-Cl-cPuMPS (
C 083); 6-MB-cAMP (
M 003); 6-MBC-cAMP (
M 012); 6-Phe-cAMP (
P 006); cPuMP (
P 010); 2-NH2-cPuMP (
A 027); DB-cAMP (
D 009)
7-modified cAMP Analogues: 7-CH-cAMP (
D 021)
8-modified cAMP Analogues: 8-AET-2'-O-Me-cAMP (
A 142); 8-Br-cAMP (
B 007); Rp-8-Br-cAMPS (
B 001); Sp-8-Br-cAMPS (
B 002); 8-Br-2'-O-Me-cAMP (
B 022); 8-Cl-cAMP (
C 007); Rp-8-Cl-cAMPS (
C 003); Sp-8-Cl-cAMPS (
C 004); 8-CPT-cAMP (
C 010); Rp-8-CPT-cAMPS (
C 011); Sp-8-CPT-cAMPS (
C 012); 8-CPT-2'-O-Me-cAMP (
C 041); 8-HA-cAMP (
H 006); 8-MA-cAMP (
M 001); 8-PIP-cAMP (
P 002); Rp-8-PIP-cAMPS (
P 004); Sp-8-PIP-cAMPS (
P 005)
2’-modified cAMP Analogues: ara-cAMP (
A 076); 2'-dcAMP (
D 015); 2'-F-cAMP (
D 073); 2'-NH2-cAMP (
A 088); 2'-O-Bn-cAMP (
B 061); MANT-cAMP (
M 008); 2'-O-MB-cAMP (
M 007); 2'-O-Me-cAMP (
M 050); 2'-O-MS-cAMP (
M 011); DB-cAMP (
D 009)
Phosphorothioate cAMP Analogues: Rp-8-Br-cAMPS (
B 001); Sp-8-Br-cAMPS (
B 002); Rp-cAMPS (
A 002); Sp-cAMPS (
A 003); Rp-2',3'-cAMPS (
A 006); Rp-2-Cl-cAMPS (
C 073); Sp-2-Cl-cAMPS (
C 074); Rp-8-Cl-cAMPS (
C 003); Sp-8-Cl-cAMPS (
C 004); Rp-5,6-DCl-cBIMPS (
D 013); Sp-5,6-DCl-cBIMPS (
D 014); Rp-8-PIP-cAMPS (
P 004); Sp-8-PIP-cAMPS (
P 005)
Parent Structure: cGMP (
G 001)
2-modified cGMP Analogues: PET-cGMP (
P 001); DB-cGMP (
D 010); cIMP (
I 001); cXMP (
X 001)
7-modified cGMP Analogues: 7-CH-cGMP (
D 099)
8-modified cGMP Analogues: 8-AET-cGMP (
A 029); 8-Br-cGMP (
B 004); Rp-8-Br-cGMPS (
B 005); Sp-8-Br-cGMPS (
B 006); 8-Br-PET-cGMP (
P 003); Rp-8-Br-PET-cGMPS (
P 007); Sp-8-Br-PET-cGMPS (
P 008); 8-pCPT-cGMP (
C 009); Rp-8-pCPT-cGMPS (
C 013); Sp-8-pCPT-cGMPS (
C 014); 8-pCPT-2'-O-Me-cGMP (
C 048)
2’-modified cGMP Analogues: 2'-dcGMP (
D 020); 2'-O-MB-cGMP (
M 006); 8-pCPT-2'-O-Me-cGMP (
C 048); MANT-cGMP (
M 009); DB-cGMP (
D 010)
Phosphorothioate cGMP Analogues: Rp-8-Br-cGMPS (
B 005); Sp-8-Br-cGMPS (
B 006); Rp-cGMPS (
G 016)
; Sp-cGMPS (
G 017)
; Rp-8-Br-PET-cGMPS (
P 007); Sp-8-Br-PET-cGMPS (
P 008); Rp-8-pCPT-cGMPS (
C 013); Sp-8-pCPT-cGMPS (
C 014)
Pyrimidine Analogues:cUMP (
U 001); 2',3'-cUMP (
U 004); cCMP (
C 001); cTMP (
T 005)
This library is permanently expanded, please inquire for current status and price.